Document:

First Amendment to Sublease dated as of July 19, 2005

 Exhibit 10.6 
 FIRST AMENDMENT TO SUBLEASE 
 This FIRST AMENDMENT TO SUBLEASE (this “Amendment”) is
made as of July 19, 2005, by and between Shreveport Doctors Hospital 2003, Ltd. (“Landlord”), a Texas limited partnership with an address of c/o Shreveport Hospital Management, Inc., its sole general partner, 1130 Louisiana
Street, Shreveport, LA 71101 and LifeCare Hospitals, Inc. (“Sublessee”), a Louisiana corporation with an address of 9320 Linwood Avenue, Shreveport, LA 71106. 
 W I T N E S S E T H: 
 WHEREAS, Landlord and Sublessee entered into a Sublease dated September 9, 2004 (the “Sublease”); 
 WHEREAS,
Landlord and Sublessee desire to amend the Sublease to extend the Sublease Term (as defined in the Sublease) and otherwise as provided below. 
 NOW THEREFORE, for good and valuable consideration, the mutual receipt and legal sufficiency of which is hereby acknowledged, Landlord and Sublessee do hereby agree as follows: 
 1. Effect of Closing under Merger Agreement. In the event that the Closing as defined in the Agreement and Plan of Merger dated of even date herewith among LifeCare Holdings, Inc., LCI Holdco, LLC, Rainier
Acquisition Corp. and Golder, Thoma, Cressey, Rauner, Inc. (the “Merger Agreement”) does not occur, Sublessee shall give written notice that the Closing has not occurred and will not occur, and this Amendment shall terminate and be
void and of no further force and effect as of the date of such notice, and the Sublease shall continue on the terms and conditions thereof prior to this Amendment. If the Closing does occur, Sublessee shall give Landlord written notice that the
Closing has occurred, and this Amendment, and the Sublease as so amended, shall continue in effect. 
 2. Amendment of Section l(t). Section l(t) is
hereby amended by deleting the words “for a period of twenty four (24) months thereafter” and replacing them with “terminating on June 30, 2007”. 
 3. Amendment of Section 7(b). Section 7(b) of the Sublease is hereby deleted in its entirety and replaced with the following: “Notwithstanding any provisions of Section 7(a) purporting to
extend beyond the Term of the Lease, the provisions of Section 7(a) shall irrevocably terminate, and both Landlord and Sublessee shall be released from any and all obligations arising under Section 7(a), upon the earlier of
(i) Sublessee’s establishment of a long term acute care facility in a location in the Territory other than (x) the Building, (y) any of the other locations currently leased or occupied by Sublessee, whether pursuant to a written
contract or otherwise, or (z) with respect to the replacement or restructuring of Sublessee’s Willis-Knighton Pierremont facility; or 

  

 -1- 

 
(ii) six (6) months prior to the expiration of the Term hereof; or (iii) Sublessee’s default of a material provision hereof and Sublessee has
not cured such default as provided for herein; or (iv) the sale, transfer or other disposition by David LeBlanc, Hedy LeBlanc, and any other persons related to David LeBlanc, of his or her entire direct or indirect interest in the Building (as
defined in the Sublease), if after such transfer no direct or indirect interest in the Building is held by David LeBlanc, any affiliate of David LeBlanc or any person related to David LeBlanc. Notwithstanding anything to the contrary herein, the
termination of Section 7(a) pursuant to this Section 7(b) shall not relive the Landlord or Sublessee of liability for any breach of Section 7(a) occurring prior to such termination. For purposes of this Section 7(b) the term
“affiliated with” or “an affiliate of shall refer only to a person or entity directly or indirectly controlled by David LeBlanc, and the term “related to” shall refer only to those natural persons who are related to David
LeBlanc by blood or marriage. Landlord and Sublessee agree to execute and deliver such other documents and instruments as may be reasonably necessary to effectuate the intent of this Section 7(b).” 
 4. Amendment to Section 36. Section 36 is hereby amended by deleting the text “5700 Tennyson Parkway” from the LifeCare Management Services,
LLC notice address and replacing it with “5560 Tennyson Parkway”. 
 5. Non-Disturbance Agreement. Landlord agrees to use its reasonable
best efforts to obtain within sixty (60) days after the date hereof a written agreement from the Master Lessor in a form reasonably acceptable to Sublessee that in the event Landlord is in default under the terms of the Master Lease, Master
Lessor shall (a) recognize the Sublease, (b) not terminate this Sublease even if Master Lessor terminates the Master Lease, in which case Master Lessor shall recognize Sublessee as its tenant under the terms and conditions of the Sublease
as a direct lease, (c) accept a cure of any default of the Landlord from Sublessee, (d) not terminate the Master Lease without first giving Sublessee the same opportunity to cure the default predicating the termination as Landlord would
have under the Master Lease (but in no event shall Sublessee be obligated to cure), and (e) send Sublessee a copy of any Notice of Default that Master Lessor delivers to Landlord. 
 6. Sale. Sublessee acknowledges that Landlord may assign its interest in the Sublease and the Master Lease to a third party (the “New Owner”) in connection with a sale of Landlord’s
hospital business in the Building (a “Landlord Sale”). Notwithstanding anything in the Sublease or this Amendment to the contrary, Sublessee agrees that if a Landlord Sale occurs on or prior to the date that is one (1) year
after the date hereof (the date of such sale being called the “Landlord Sale Date”), Sublessee shall use its reasonable best efforts within one (1) year after the Landlord Sale Date, at Sublessee’s sole election, to either
(i) relocate its business from the Premises, in which event the Sublease shall terminate and neither party shall have any further obligation to the other on the date on which Sublessee vacates the Premises, or (ii) negotiate in good faith
with the New Owner as to mutually agreeable terms to extend the Sublease. Nothing in this paragraph shall obligate Sublessee to do anything more than exercise reasonable best efforts to proceed with one of the two options described in the
immediately preceding sentence. 
 7. Broker. Landlord and Sublessee each represent and warrant to the other that it has not dealt with any broker in
connection with this Amendment and will indemnify and hold harmless 

  

 -2- 

 
the other from and against any loss and expenses suffered by either of them as a result of such dealings with any broker. 
 8. Prime Lessor’s Consent. Landlord represents that no consent of Master Lessor is required for this Amendment under the terms of the Master Lease.

 9. Confirmation. Except as amended hereby, the Sublease is hereby confirmed and continues in full force and effect. 
 10. Counterparts. This Amendment may be executed in one or more counterparts which together shall constitute one instrument. 
 11. Terms; Section References. Terms used herein and not defined herein are used herein as defined in the Sublease. References herein to Sections of the Sublease
which use “( )” to denote clauses refer to applicable sections of the Sublease even where such parentheses may not be used or “.” (or, at various points, “( )” or “.”) are used instead in the Sublease.

 [Remainder of this Page Intentionally Left Blank] 
  

 -3- 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment, as a sealed instrument, as of the
date first above written. 
  

			
	 LANDLORD:

	
	Shreveport Doctors Hospital 2003, Ltd., a Texas limited partnership
		
	 By:
	 	Shreveport GP, LLC, its sole general partner
		
	 By:
	 	 /s/ B. John Lange

		 	 Name: B. John Lange, III

		 	 Title: President

	
	 SUBLESSEE:

	
	LifeCare Hospitals, Inc., a Louisiana corporation
		
	 By:
	 	 /s/ Jimmie M. Stapleton

		 	 Name: Jimmie M. Stapleton

		 	 Title: EVPStockholders Agreement dated as of August 11, 2005

 Exhibit 10.7 

  
 STOCKHOLDERS AGREEMENT 
  
 among 
  
 LCI Holding Company, Inc. 
  
 LCI Intermediate Holdco, Inc. 
  
 LCI Holdco, LLC 
  
 Rainier Acquisition Corp. 
  
 and 
  
 Certain Stockholders of LCI
Holding Company, Inc. 
  
 Dated as of August 11, 2005

  

 TABLE OF CONTENTS 
  

							
	 1.
	 	EFFECTIVENESS; DEFINITIONS	  	2
	 	 	 1.1.
	  	Closing	  	2
	 	 	 1.2.
	  	Definitions	  	2
	 2.
	 	VOTING AGREEMENT	  	2
	 	 	 2.1.
	  	Certain Actions	  	2
	 	 	 2.2.
	  	Directors of the Company and its Subsidiaries	  	4
	 	 	 2.3.
	  	Significant Transactions	  	5
	 	 	 2.4.
	  	The Company	  	5
	 	 	 2.5.
	  	Period	  	5
	 3.
	 	TRANSFER RESTRICTIONS	  	6
	 	 	 3.1.
	  	Transfers Allowed	  	6
	 	 	 3.2.
	  	Certain Transferees to Become Parties	  	7
	 	 	 3.3.
	  	Restrictions on Public Transfers under Rule 144	  	7
	 	 	 3.4.
	  	Restrictions on Transfers to Strategic Investors	  	7
	 	 	 3.5.
	  	Impermissible Transfer	  	8
	 	 	 3.6.
	  	Notice of Transfer	  	8
	 	 	 3.7.
	  	Period	  	8
	 4.
	 	“TAG ALONG” AND “DRAG ALONG” RIGHTS AND RIGHT OF FIRST OFFER	  	8
	 	 	 4.1.
	  	Tag Along	  	8
	 	 	 4.2.
	  	Drag Along	  	10
	 	 	 4.3.
	  	Miscellaneous	  	11
	 	 	 4.4.
	  	Right of First Offer	  	13
	 	 	 4.5.
	  	Period	  	16
	 5.
	 	RIGHT OF PARTICIPATION	  	16
	 	 	 5.1.
	  	Right of Participation	  	16
	 	 	 5.2.
	  	Post-Issuance Notice	  	19
	 	 	 5.3.
	  	Excluded Transactions	  	20
	 	 	 5.4.
	  	Certain Provisions Applicable to Options, Warrants and Convertible Securities	  	20
	 	 	 5.5.
	  	Acquired Shares	  	21
	 	 	 5.6.
	  	Period	  	21
	 6.
	 	COVENANTS	  	21
	 	 	 6.1.
	  	Information Rights	  	21
	 	 	 6.2.
	  	Confidentiality	  	22
	 7.
	 	REMEDIES	  	22
	 	 	 7.1.
	  	Generally	  	22
	 	 	 7.2.
	  	Deposit	  	22
	 8.
	 	LEGENDS	  	23
	 	 	 8.1.
	  	Restrictive Legend	  	23
	 	 	 8.2.
	  	1933 Act Legends	  	23
	 	 	 8.3.
	  	Stop Transfer Instruction	  	24
	 	 	 8.4.
	  	Termination of 1933 Act Legend	  	24
	 9.
	 	AMENDMENT, TERMINATION, ETC.	  	24
	 	 	 9.1.
	  	Oral Modifications	  	24
	 	 	 9.2.
	  	Written Modifications	  	24
	 	 	 9.3.
	  	Effect of Termination	  	24

  

 -i- 

							
	 10.
	 	DEFINITIONS	  	24
	 	 	 10.1.
	  	Certain Matters of Construction	  	24
	 	 	 10.2.
	  	Definitions	  	25
	 11.
	 	MISCELLANEOUS	  	31
	 	 	 11.1.
	  	Authority: Effect	  	31
	 	 	 11.2.
	  	Notices	  	31
	 	 	 11.3.
	  	Binding Effect, Etc.	  	32
	 	 	 11.4.
	  	Descriptive Heading	  	33
	 	 	 11.5.
	  	Counterparts	  	33
	 	 	 11.6.
	  	Severability	  	33
	 	 	 11.7.
	  	No Recourse	  	33
	 	 	 11.8.
	  	Aggregation of Shares	  	33
	 	 	 11.9.
	  	Obligations of Company, Midco, Holdco and Merger Sub	  	33
	 12.
	 	GOVERNING LAW	  	34
	 	 	 12.1.
	  	Governing Law	  	34
	 	 	 12.2.
	  	Consent to Jurisdiction	  	34
	 	 	 12.3.
	  	WAIVER OF JURY TRIAL	  	34
	 	 	 12.4.
	  	Exercise of Rights and Remedies	  	35

  

 -ii- 

 STOCKHOLDERS AGREEMENT 
  
 This Stockholders Agreement (the “Agreement”) is made as of August 11, 2005 by and among: 

 

	 	(i)	LCI Holding Company, Inc., a Delaware corporation (together with its successors and permitted assigns, the “Company”); 

  

	 	(ii)	LCI Intermediate Holdings, Inc., a Delaware corporation (together with its successors and permitted assigns, “Midco”); 

  

	 	(iii)	LCI Holdco LLC, a Delaware limited liability company (together with its successors and permitted assigns, “Holdco”); 

  

	 	(iv)	Rainier Acquisition Corp., a Delaware corporation (together with its successors and permitted assigns, “Merger Sub.”); 

  

	 	(v)	each Person executing this Agreement and listed as an Investor on the signature pages hereto (collectively with their Permitted Transferees, the “Investors”);

  

	 	(vi)	each Person executing this Agreement and listed as a manager on the signature pages hereto (collectively with their Permitted Transferees, the “Managers”);

  

	 	(vii)	such other Persons, if any, that from time to time become party hereto as transferees of Shares pursuant to Section 3.2 (collectively, together with the Investors and the
Managers, the “Stockholders”) in accordance with the terms hereof. 

  
 RECITALS 
  
 1. The Company has been formed for the purpose of acquiring (the “Acquisition”), indirectly through one or more subsidiaries, pursuant to an Agreement and Plan of Merger, dated as of July 19,
2005 (the “Merger Agreement”), among Holdco, Merger Sub., LifeCare Holdings, Inc. (“LifeCare”) and Golder, Thoma, Cressey, Rauner, Inc., in its capacity as Representative for the security holders of LifeCare, all of
the outstanding shares of LifeCare. Immediately after the Closing (as defined below), Merger Sub. will merge with and into LifeCare. 
  
 2. Upon the Closing (as defined below), the Common Stock (as defined below) of the Company will be held as set forth on Schedule I hereto.

  
 3. The parties believe that it is in the best interests of the
Company, Midco, Holdco, Merger Sub. and the Stockholders to set forth their agreements on certain matters. 

 AGREEMENT 
  
 Therefore, the parties hereto hereby agree as follows: 
  
 1. EFFECTIVENESS; DEFINITIONS. 
  
 1.1. Closing. This Agreement shall become effective upon consummation of the closing under the Acquisition Agreement (the
“Closing”). 
  
 1.2. Definitions. Certain
terms are used in this Agreement as specifically defined herein. These definitions are set forth or referred to in Section 10 hereof. 
  
 2. VOTING AGREEMENT. 
  
 2.1. Certain Actions. In addition to any other approval required by the certificate of incorporation of the Company, Midco, or LifeCare or by
applicable law, the approval of Carlyle Partners IV shall be required to do any of the following, and the Company, Midco, Holdco and Merger Sub. shall not, and shall cause their respective subsidiaries not to, take any of the following actions
without the approval of Carlyle Partners IV, who shall have the right to substantially participate in and substantially influence the conduct of the management of the Company and its subsidiaries: 
  
 2.1.1. Annual Budget. Approve the annual operating
budget of the Company and its subsidiaries, modify in any material respect any such budget or take any action that is or would be reasonably likely to be in material variance therefrom. 
  
 2.1.2. Merger, Consolidation, Change of Control. Enter into or effect any transaction or series of
related transactions involving the merger or consolidation of the Company or any of its subsidiaries with or into any Person, other than a merger or consolidation of a direct or indirect wholly-owned subsidiary of the Company with or into the
Company or another direct or indirect wholly-owned subsidiary of the Company; or enter into or effect a Change of Control transaction. 
  
 2.1.3. Indebtedness, etc. Other than a draw down in the ordinary course of business under a debt agreement entered into prior to
the date of such draw down the execution of which was previously approved by the Majority Carlyle Investors, incur any indebtedness (including refinancings), assume, guarantee, endorse or otherwise as an accommodation become responsible for the
obligations of any other Person (provided that the Company or any of its direct or indirect subsidiaries may provide cross-guarantees for any indebtedness that has been approved under this Section 2.1.3), enter into any agreement under which it
may incur indebtedness in the future, make any voluntary prepayment of indebtedness of the Company or any of its subsidiaries outside the ordinary course of business, in each case in an aggregate amount in excess of $1,000,000 in any transaction or
series of related transactions, or make an amendment to the maturity date, aggregate principal amount or interest rate of existing indebtedness, or make any loan, advance or capital contribution to any Person (other than the Company or any of its
wholly-owned subsidiaries),. 
  

 -2- 

 2.1.4. Sale of Assets. Enter into or effect any transaction or series of related
transactions, involving the sale, lease, exchange or other disposal by the Company or any of its subsidiaries of any assets for consideration having a fair market value (as reasonably determined by the Board) in excess of $1,000,000, other than
transactions between and among any of the Company and its direct or indirect wholly-owned subsidiaries. 
  
 2.1.5. Acquisition of Assets. Enter into or effect any transaction or series of related transactions, involving the purchase, rent,
license, exchange or other acquisition by the Company or any of its subsidiaries of any assets for consideration having a fair market value (as reasonably determined by the Board) in excess of $1,000,000. 
  
 2.1.6. Repurchase of Securities. Enter into or effect
any transaction or series of related transactions in connection with or involving the repurchase, redemption or other acquisition of securities of the Company or any of its subsidiaries or in connection with any management incentive program other
than (i) repurchases from Investors and (ii) repurchases from, or payments to, managers up to an aggregate of $100,000 with respect to any single manager. 
  
 2.1.7. Charter and By-laws. Amend or waive any material provisions of the certificate of
incorporation or by-laws of the Company or any of its subsidiaries. 
  
 2.1.8. Acquisition Documents. Amend or waive any material provisions of or otherwise terminate the Acquisition Agreement and any ancillary documents entered into in connection with the Acquisition, including
the Credit Agreements and the Indenture (including, in each case, any amendments, restatements or refinancings or replacements thereof). For purposes of this Section 2.1.8, the term “Credit Agreements” means the Credit
Agreement dated as of August 11, 2005 among LifeCare, Holdco, each lender from time to time party thereto, JPMorgan Chase Bank, N.A., J.P. Morgan Securities, Inc., GECC Capital Markets Group, Inc., General Electric Capital Corporation and Banc
of America Securities LLC; and the term “Indenture” means the Indenture dated as of August 11, 2005 between Merger Subsidiary and U.S. Bank, National Association, as Trustee. 
  
 2.1.9. Executive Officers. Hire or remove, with or
without cause, the chief executive officer, the chief financial officer, the chief operating officer or any other member of senior management of the Company, Midco, Holdco or Merger Sub., from time to time. 
  
 2.1.10. Management Transactions. Enter into or effect
directly or indirectly any transaction between the Company or one of its subsidiaries, on the one hand, and a member of senior management or any Affiliate thereof, on the other. 
  
 2.1.11. Equity Issuances. Issue or sell, exchange or otherwise transfer any of its equity securities
other than issuances or transfers of equity securities of a subsidiary to the Company or to a wholly-owned subsidiary of the Company. 
  

 -3- 

 2.1.12. Acquisition of Securities. Purchase, exchange or otherwise acquire any
equity securities of any other Person, other than the acquisition of equity of a direct or indirect wholly-owned subsidiary of the Company. 
  
 2.1.13. Reorganization. Dissolve, liquidate or engage in any recapitalization or reorganization of the Company or any subsidiary
(other than a wholly-owned subsidiary other than LifeCare) or the filing for bankruptcy by the Company or any of its subsidiaries. 
  
 2.1.14. Dividends. Declare or pay any cash or other dividend or make any other distribution on the capital stock of the Company or
on the capital stock of any subsidiary other than dividends or other distributions by a direct or indirect wholly-owned subsidiary of the Company to its equity holder. 
  
 2.1.15. Material Contracts Outside the Ordinary Course of Business. Enter into any contract involving
payments to or from the Company and/or its subsidiaries in excess of $1,000,000 other than any such contract that is in accordance with the annual budget approved under Section 2.1.1 and entered into in the ordinary course of business.

  
 2.1.16. Recapitalization. Recapitalize
or reclassify existing securities or enter into, or effect, any exchange or tender offer. 
  
 2.1.17. Litigation. Settle any claim or litigation for an amount in excess of $1,000,000. 
  
 2.1.18. Nature of Business. Materially change the
nature of the business of the Company or its subsidiaries. 
  
 2.1.19. Financial Auditors. Hire or remove, with or without cause, the independent auditors of the Company. 
  
 2.1.20. Establishment of Subsidiary. Create or permit to exist any subsidiary of the Company, other than a wholly-owned subsidiary.

  
 2.1.21. Management Equity or Severance
Programs. Adopt or make a material amendment to any severance or management equity program. 
  
 2.1.22. Joint Ventures and Alliances. Enter into any joint venture or business alliance other than in the ordinary course of
business that has an aggregate value in excess of $1,000,000 in one transaction or series of transactions. 
  
 2.1.23. Agreement. Agree to do any of the foregoing in Sections 2.1.1 through 2.1.22. 
  

 -4- 

 2.2. Directors of the Company and its Subsidiaries. 
  
 2.2.1. Board of Directors. Each Stockholder agrees to
cast all votes to which such Stockholder is entitled in respect of the Shares, whether at any annual or special meeting, by written consent or otherwise, to establish and maintain a Board consisting of the numbers of directors (not less than three)
designated from time to time by the Majority Carlyle Investors. 
  
 2.2.2. Carlyle Partners IV Director. Each Stockholder agrees to cast all votes to which such Stockholder is entitled in respect of the Shares, whether at any annual or special meeting, by written consent or
otherwise, (a) to elect one or more designees of Carlyle Partners IV to the Board of the Company pursuant to the Company’s certificate of incorporation (the “Carlyle Director”) and (b) to remove any such Carlyle
Director if at any time requested to do so by Carlyle Partners IV. 
  
 2.2.3. CEO Director. Each Stockholder agrees to cast all votes to which such Stockholder is entitled in respect of the Shares, whether at any annual or special meeting, by written consent or otherwise,
(a) to elect the Chief Executive Officer of Merger Sub. to the Board of the Company pursuant to the Company’s certificate of incorporation (the “CEO Director”) and (b) to remove the CEO Director if at any time the
person serving as CEO Director ceases to be the Chief Executive Officer of Merger Sub. 
  
 2.2.4. Directors of Subsidiaries. The Company will cause the board of directors of Midco and Merger Sub. and the board of managers
of Holdco to consist at all times of the same members as the Board of the Company at such time. The boards of directors (or similar managing authority) of all other subsidiaries of the Company will consist of such persons as the Company shall
direct. 
  
 2.3. Significant Transactions. Each Stockholder
agrees to cast all votes to which such Stockholder is entitled in respect of the Shares, whether at any annual or special meeting, by written consent or otherwise, in such manner as the Majority Carlyle Investors may instruct by written notice to
approve any sale, recapitalization, merger, consolidation, reorganization or any other transaction or series of transactions involving the Company or its subsidiaries (or all or any portion of their respective assets) in connection with, or in
furtherance of, the exercise by the Majority Carlyle Investors of their rights under Section 4.2. Each Stockholder hereby grants to Carlyle Partners IV an irrevocable proxy coupled with an interest to vote, including in any action by written
consent, such Stockholder’s Shares in accordance with such Stockholder’s agreements contained in this Section 2.3, which proxy shall be valid and remain in effect until the provisions of this Section 2.3 expire pursuant to
Section 2.5. 
  
 2.4. The Company. The Company will
not give effect to any action by any Stockholder or any other Person which is in contravention of this Section 2. 
  
 2.5. Period. Each of the foregoing provisions of this Section 2 shall expire upon a Change of Control. 
  

 -5- 

 3. TRANSFER RESTRICTIONS. 
  

3.1. Transfers Allowed. No Stockholder shall Transfer any of such Stockholder’s Shares to any other Person except as follows: 

 
 3.1.1. Permitted Transferees. Subject to
Section 3.4, but without regard to any other restrictions on transfer contained elsewhere in this Agreement, any Stockholder may Transfer any or all of such Shares to such Stockholder’s Permitted Transferees. 
  
 3.1.2. Distributions and Charitable Contributions. At
or after the closing of the Initial Public Offering, any Stockholder may Transfer any or all of such Shares in a pro rata Transfer to its partners, members or stockholders without regard to any other restrictions on transfer contained elsewhere
in this Agreement. Any Shares so Transferred shall conclusively be deemed thereafter not to be Shares under this Agreement. 
  
 3.1.3. Public Transfers. Any Stockholder may Transfer any or all of such Shares: (a) in a Public Offering or (b) after
the closing of the Initial Public Offering, pursuant to Rule 144 or a block sale to a financial institution in the ordinary course of its trading business, in each case in compliance with Section 3.3 and Section 3.4, but without regard to
any other restrictions on transfer contained elsewhere in this Agreement. Shares Transferred in accordance with this Section 3.1.3 shall conclusively be deemed thereafter not to be Shares under this Agreement. 
  
 3.1.4. Tag Along and Drag Along. 
  
 (i) Any Stockholder may Transfer any or all of such Shares
pursuant to Section 4.2, without regard to any other restrictions on transfer contained elsewhere in this Agreement. Any Shares so Transferred shall conclusively be deemed thereafter not to be Shares under this Agreement. 
  
 (ii) A Participating Seller may Transfer Shares pursuant to
and in accordance with the provisions of Section 4.1 without regard to any other restrictions on transfer contained elsewhere in this Agreement provided that each transferee agrees to be bound by the terms of this Agreement in accordance with
Section 3.2 (if not already bound hereby). 
  
 3.1.5. Other Private Transfers. In addition to any Transfers made in accordance with Sections 3.1.1, 3.1.2, 3.1.3 and 3.1.4, any Stockholder may Transfer any or all of such Shares subject to compliance with all of the following
conditions in respect of each Transfer: 
  
 (i)
if such Transfer is prior to the seven year anniversary of the date of the Closing, with the consent of the Majority Carlyle Investors and in compliance with Sections 3.2, 3.4 and 4.1, and if such Transfer is before the closing of the Initial Public
Offering and by a Stockholder other than an Investor, Section 4.4; and 
  

 -6- 

 (ii) if such Transfer is after the seven year anniversary of the date of the Closing, in
compliance with Sections 3.2, 3.4 and 4.1 and, if such Transfer is before the closing of the Initial Public Offering, and by a Stockholder other than an Investor, Section 4.4. 
  
 Any Shares so Transferred shall conclusively be deemed thereafter to be Shares under this Agreement and each transferee
shall be bound by the terms of this Agreement in accordance with Section 3.2. 
  
 3.2. Certain Transferees to Become Parties. Any transferee receiving Shares in a Transfer pursuant to Section 3.1.1, 3.1.4(ii) or 3.1.5 shall become a Stockholder, party to this Agreement and subject to
the terms and conditions of, and be entitled to enforce, this Agreement to the same extent, and in the same capacity, as the Person that Transfers such Shares to such transferee; provided, however, that only a Permitted Transferee of
an Investor will be deemed to be an Investor for purposes of this Agreement and provided, further, that any transferee receiving Shares in a Transfer pursuant to Section 3.1.4(ii) or 3.1.5 that is neither a Permitted Transferee
nor an Investor will become party to this Agreement as Stockholder without the benefit of the rights of: (a) Tag Along Holders (Section 4.1.1); (b) First Offer Holders (Section 4.4), or (c) Participation Offerees (Section 5).
Prior to the Transfer of any Shares to any transferee pursuant to Section 3.1.1, 3.1.4(ii) or 3.1.5, and as a condition thereto, each Stockholder effecting such Transfer shall (x) cause such transferee to deliver to the Company and each of
the Investors (other than the transferor) its written agreement, in form and substance reasonably satisfactory to the Company, to be bound by the terms and conditions of this Agreement to the extent described in the preceding sentence and
(y) if such Transfer is to a Permitted Transferee, remain directly liable for the performance by such Permitted Transferee of all obligations of such transferee under this Agreement. 
  
 3.3. Restrictions on Public Transfers under Rule 144. After the Initial Public Offering, each Specified Holder
promptly shall notify each Related Holder (a) when it has commenced a measurement period for purposes of the Rule 144 group volume limit in connection with a Sale that is subject to such limit and (b) what the volume limit for that
measurement period, determined as of its commencement, will be. Each Related Holder shall be entitled to effect Sales that are subject to the Rule 144 group volume limit pro rata during the applicable measurement period based on its percentage
ownership of Shares held by all holders of Shares at the start of such measurement period. In the event any Related Holder agrees to forego its full pro rata share of the Rule 144 group volume limit by written notice to the Specified Holder and all
other Related Holders, the remainder shall be re-allocated pro rata among the Specified Holder and all other Related Holders in like manner (except that the Shares held by such forfeiting Related Holder at the start of such measurement period shall
be excluded from such calculation). The provisions of this Section 3.3 shall not apply to any Transfer of Shares (x) in a Public Offering or (y) not subject to volume limitation under Rule 144. For purposes of this Section 3.3, a
“Specified Holder” means a Stockholder whose sale of Shares pursuant to Rule 144 would be subject to aggregation with another Stockholder (such other Stockholder being a “Related Holder”). 
  
 3.4. Restrictions on Transfers to Strategic Investors. In addition to
any other provision of this Agreement, no Stockholder shall Transfer any Shares pursuant to Sections 3.1.1, 3.1.3 or 

  

 -7- 

 
3.1.5 of this Agreement to a Strategic Investor without the approval of the Majority Carlyle Investors; provided, however, that the
restrictions in this Section 3.4 shall not apply to any Transfers (v) to the Company or any of its subsidiaries, (w) to any Investor, (x) to any Affiliated Fund of any Investor, (y) pursuant to Rule 144 effected as
“brokers’ transactions” (as defined in Rule 144); or (z) pursuant to an underwritten Public Offering or, following the Initial Public Offering, in any transaction in which, to the knowledge of the Stockholder (after
reasonable due inquiry), none of the purchaser(s), underwriter(s), if any, nor market maker(s), if any, are acquiring such Shares for the intended purpose of reselling such Shares to any Person that, after giving effect to such resale (if
applicable), would own, directly or indirectly, more than five percent (5%) of then outstanding shares of the applicable class of Shares. 
  
 3.5. Impermissible Transfer. Any attempted Transfer of Shares not permitted under the terms of this Section 3 shall be null and void, and the
Company shall not in any way give effect to any such impermissible Transfer. 
  
 3.6. Notice of Transfer. To the extent any Stockholder or Permitted Transferee shall Transfer any Shares, such Stockholder or Permitted Transferee shall, within three Business Days following consummation of
such Transfer, deliver notice thereof to the Company and each Investor. 
  
 3.7. Period. Each of the foregoing provisions of this Section 3 shall expire upon a Change of Control. 
  
 4. “TAG ALONG” AND “DRAG ALONG” RIGHTS AND RIGHT OF FIRST OFFER. 
  
 4.1. Tag Along. Subject to prior compliance with Section 4.4, if applicable, if any Prospective Selling
Stockholder proposes to Sell any Shares to any Prospective Buyer(s) that is not a Permitted Transferee (including a First Offer Purchaser pursuant to Section 4.4) in a Transfer that is subject to Section 3.1.5: 
  
 4.1.1. Notice. The Prospective Selling Stockholder
shall, prior to any such proposed Transfer, deliver a written notice (the “Tag Along Notice”) to each Stockholder (each, a “Tag Along Holder”). The Tag Along Notice shall include: 
  
 (i) the principal terms and conditions of the proposed Sale,
including (i) the number and class of the Shares to be purchased from the Prospective Selling Stockholder, (ii) the fraction(s) expressed as a percentage, determined by dividing the number of Shares of each class to be purchased from the
Prospective Selling Stockholder by the total number of Equivalent Shares of each such class held by the Prospective Selling Stockholder (for each class, the “Tag Along Sale Percentage”) (it being understood that the Company shall
reasonably cooperate with the Prospective Selling Stockholder in respect of the determination of each applicable Tag Along Sale Percentage), (iii) the per share purchase price or the formula by which such price is to be determined and the
payment terms, including a description of any non-cash consideration sufficiently detailed to permit valuation thereof, (iv) the name and address of each Prospective Buyer and (v) the proposed Transfer date; and 
  

 -8- 

 (ii) an invitation to each Tag Along Holder to make an offer to include in the proposed
Sale to the applicable Prospective Buyer(s) Equivalent Shares of the same class(es) being sold by the Prospective Selling Stockholder held by such Tag Along Holder (not in any event to exceed the Tag Along Sale Percentage of the total number of
Equivalent Shares of the applicable class held by such Tag Along Holder), on the same terms and conditions (subject to Section 4.3.4 in the case of Options, Warrants and Convertible Securities and subject to Section 4.3.1 under all
circumstances), with respect to each Share Sold, as the Prospective Selling Stockholder shall Sell each of its Shares. 
  
 4.1.2. Exercise. Within ten (or five, if the proposed Transfer is also the subject of a currently effective Sale Notice under
Section 4.4) Business Days after the date of delivery of the Tag Along Notice (such date the “Tag Along Deadline”), each Tag Along Holder desiring to make an offer to include Shares in the proposed Sale (each a
“Participating Seller” and, together with the Prospective Selling Stockholder, collectively, the “Tag Along Sellers”) shall deliver a written notice (the “Tag Along Offer”) to the Prospective
Selling Stockholder indicating the number of Shares which such Participating Seller desires to have included in the proposed Sale (subject to the limitation set forth in Section 4.1.1(ii) ). Each Tag Along Holder who does not make a Tag Along
Offer in compliance with the above requirements, including the time period, shall be deemed to have waived all of such holder’s rights to participate in such Sale, and the Tag Along Sellers shall thereafter be free to Sell to the Prospective
Buyer, at a per share price no greater than the per share price set forth in the Tag Along Notice and on other principal terms and conditions which are not materially more favorable to the Tag Along Sellers than those set forth in the Tag Along
Notice, without any further obligation to such non-accepting Tag Along Holder pursuant to this Section 4.1. 
  
 4.1.3. Irrevocable Offer. The offer of each Participating Seller contained in such holder’s Tag Along Offer shall be
irrevocable, and, to the extent such offer is accepted, such Participating Seller shall be bound and obligated to Sell in the proposed Sale on the same terms and conditions, with respect to each Share Sold (subject to Section 4.3.4 in the case
of Options, Warrants and Convertible Securities), as the Prospective Selling Stockholder, up to such number of Shares as such Participating Seller shall have specified in such holder’s Tag Along Offer; provided, however, that if
the principal terms of the proposed Sale change with the result that the per share price shall be less than the per share price set forth in the Tag Along Notice or the other principal terms and conditions shall be materially less favorable to the
Tag Along Sellers than those set forth in the Tag Along Notice, the Prospective Seller shall provide written notice thereof to each Participating Seller and each Participating Seller shall be permitted to withdraw the offer contained in such
holder’s Tag Along Offer by written notice to the Prospective Selling Stockholder within three Business Days of delivery of such written notice from the Prospective Selling Stockholder and upon such withdrawal shall be released from such
holder’s obligations thereunder. 
  
 4.1.4.
Reduction of Shares Sold. The Prospective Selling Stockholder shall attempt to obtain the inclusion in the proposed Sale of the entire number of Shares which each of the Tag Along Sellers requested to have included in the Sale (as evidenced
in the 

  

 -9- 

 
case of the Prospective Selling Stockholder by the Tag Along Notice and in the case of each Participating Seller by such Participating Seller’s Tag
Along Offer). In the event the Prospective Selling Stockholder shall be unable to obtain the inclusion of such entire number of Shares in the proposed Sale, the number of Shares to be sold in the proposed Sale shall be allocated among the Tag Along
Sellers in proportion, as nearly as practicable, as follows: 
  
 (i) there shall be first allocated to each Tag Along Seller a number of Shares equal to the lesser of (i) the number of Shares offered (or proposed, in the case of the Prospective Selling Stockholder) to be
included by such Tag Along Seller in the proposed Sale pursuant to this Section 4.1, and (ii) a number of Shares equal to such Tag Along Seller’s Pro Rata Portion; and 
  
 (ii) the balance, if any, not allocated pursuant to clause (a) above shall be allocated to the
Prospective Selling Stockholder, or in such other manner as the Prospective Selling Stockholder may otherwise agree (it being understood that no Tag Along Seller will be obligated to sell more Shares than it offered to sell in the proposed Sale).

  
 4.1.5. Additional Compliance. If,
prior to consummation, the terms of the proposed Sale shall change with the result that the per share price to be paid in such proposed Sale shall be greater than the per share price set forth in the Tag Along Notice or the other principal terms of
such proposed Sale shall be materially more favorable to the Tag Along Sellers than those set forth in the Tag Along Notice, the Tag Along Notice shall be null and void, and it shall be necessary for a separate Tag Along Notice to be delivered, and
the terms and provisions of this Section 4.1 separately complied with, in order to consummate such proposed Sale pursuant to this Section 4.1; provided, however, that in the case of such a separate Tag Along Notice, the
applicable period to which reference is made in Section 4.1.2 shall be three Business Days and two Business Days, respectively. In addition, if the Prospective Selling Stockholders have not completed the proposed Sale by the end of the 180th
day after the date of delivery of (a) if the proposed Transfer is also the subject of a currently effective Sale Notice under Section 4.4, such Sale Notice, and (b) otherwise, the Tag Along Notice, each Participating Seller shall be
released from such holder’s obligations under such holder’s Tag Along Offer, the Tag Along Notice shall be null and void, and it shall be necessary for a separate Tag Along Notice to be delivered, and the terms and provisions of this
Section 4.1 separately complied with, in order to consummate such proposed Sale pursuant to this Section 4.1, unless the failure to complete such proposed Sale resulted from any failure by any Participating Seller to comply with the terms
of this Section 4. 
  
 4.2. Drag Along. Each
Stockholder hereby agrees, if requested by the Majority Carlyle Investors, to Sell the same percentage (the “Drag Along Sale Percentage”) of the total number of Equivalent Shares of each class of such Shares that is proposed to be
sold by the Prospective Selling Stockholders to a Prospective Buyer (in one transaction or a series of related transactions), in the manner and on the terms set forth in this Section 4.2. 
  

 -10- 

 4.2.1. Exercise. The Prospective Selling Stockholders shall deliver a written
notice (the “Drag Along Notice”) to each other Stockholder at least ten Business Days prior to the consummation of the Change of Control transaction. The Drag Along Notice shall set forth the principal terms and conditions of the
proposed Sale, including (a) the number and class of Shares to be acquired from the Prospective Selling Stockholders, (b) the Drag Along Sale Percentage for each class, (c) the per share consideration to be received in the proposed
Sale for each class, (d) the name and address of the Prospective Buyer and (e) if known, the proposed Transfer date. If the Prospective Selling Stockholders consummate the proposed Sale to which reference is made in the Drag Along Notice,
each other Stockholder (each, a “Participating Seller,” and, together with the Prospective Selling Stockholders, collectively, the “Drag Along Sellers”) shall: (i) be bound and obligated to Sell the Drag Along
Sale Percentage of such holder’s Shares of each class in the proposed Sale on the same terms and conditions, with respect to each Share Sold (subject to Section 4.3.4 in the case of Options, Warrants and Convertible Securities) as the
Prospective Selling Stockholders shall Sell each Share in the Sale (subject to Section 4.3.4 in the case of Options, Warrants and Convertible Securities and subject to Section 4.3.1 under all circumstances); and (ii) except as
provided in Section 4.3.1, shall receive the same form and amount of consideration per Share to be received by the Prospective Selling Stockholders for the corresponding class of Shares (on an as converted basis, in the case of Convertible
Securities). Except as provided in Section 4.3.1, if any holders of Shares of any class are given an option as to the form and amount of consideration to be received, all holders of Shares of such class will be given the same option. Unless
otherwise agreed by each Drag Along Seller, any non-cash consideration shall be allocated among the Drag Along Sellers pro rata based upon the aggregate amount of consideration to be received by such Drag Along Sellers. If at the end of the 180th
day after the date of delivery of the Drag Along Notice the Prospective Selling Stockholders have not completed the proposed Sale, the Drag Along Notice shall be null and void, each Participating Seller shall be released from such holder’s
obligation under the Drag Along Notice and it shall be necessary for a separate Drag Along Notice to be delivered and the terms and provisions of this Section 4.2 separately complied with, in order to consummate such proposed Sale pursuant to
this Section 4.2. 
  
 4.3. Miscellaneous. The
following provisions shall be applied to any proposed Sale to which Sections 4.1, 4.2 or 4.4 applies: 
  
 4.3.1. Certain Legal Requirements. In the event the consideration to be paid in exchange for Shares in a proposed Sale pursuant to
Section 4.1 or Section 4.2 includes any securities, and the receipt thereof by a Participating Seller would require under applicable law (a) the registration or qualification of such securities or of any Person as a broker or dealer
or agent with respect to such securities where such registration or qualification is not otherwise required for the Sale by the Prospective Selling Stockholder(s) or (b) the provision to any Tag Along Seller or Drag Along Seller of any
specified information regarding such securities or the issuer thereof that is not otherwise required to be provided for the Sale by the Prospective Selling Stockholder(s), then such Participating Seller shall not have the right without the consent
of the Prospective Selling Stockholder(s) to Sell Shares in such proposed Sale. In such event, absent such 

  

 -11- 

 
consent, the Prospective Selling Stockholder(s) shall (i) in the case of a Sale pursuant to Section 4.1, have the right, but not the obligation,
and (ii) in the case of a Sale pursuant to Section 4.2, have the obligation to cause to be paid to such Participating Seller in lieu thereof, against surrender of the Shares (in accordance with Section 4.3.6 hereof) which would have
otherwise been Sold by such Participating Seller to the Prospective Buyer in the proposed Sale, an amount in cash equal to the Fair Market Value of such Shares as of the date such securities would have been issued in exchange for such Shares.

  
 4.3.2. Further Assurances. Each
Participating Seller and First Offer Purchaser shall take or cause to be taken all such actions as may be necessary or reasonably desirable in order expeditiously to consummate each Sale pursuant to Section 4.1, Section 4.2 or
Section 4.4 and any related transactions, including executing, acknowledging and delivering consents, assignments, waivers and other documents or instruments; furnishing information and copies of documents; filing applications, reports,
returns, filings and other documents or instruments with governmental authorities; and otherwise cooperating with the Prospective Selling Stockholder(s) and the Prospective Buyer; provided, however, that Participating Sellers shall be
obligated to become liable in respect of any representations, warranties, covenants, indemnities or otherwise to the Prospective Buyer solely to the extent provided in the immediately following sentence. Without limiting the generality of the
foregoing, each Participating Seller agrees to execute and deliver such agreements as may be reasonably specified by the Prospective Selling Stockholder(s) to which such Prospective Selling Stockholder(s) will also be party, including agreements to
(a) (i) make individual representations, warranties, covenants and other agreements as to the unencumbered title to its Shares and the power, authority and legal right to Transfer such Shares, the absence of any Adverse Claim with respect
to such Shares and the non-contravention of other agreements and (ii) be liable as to such representations, warranties, covenants and other agreements, in each case to the same extent (but with respect to its own Shares) as the Prospective
Selling Stockholder(s), and (b) in the case of a Sale pursuant to Sections 4.1 or 4.2, be liable (whether by purchase price adjustment, indemnity payments or otherwise) in respect of representations, warranties, covenants and agreements in
respect of the Company and its subsidiaries; provided, however, that the aggregate amount of liability referred to in this clause (b) in connection with any Sale of Shares shall not exceed such Participating Seller’s pro rata
portion of any such liability, to be determined in accordance with such Participating Seller’s portion of the aggregate proceeds to all Participating Sellers and Prospective Selling Stockholder(s) in connection with such Sale; and
provided further that the aggregate amount of liability referred to in this sentence shall not exceed the proceeds to such Participating Seller in connection with such Sale. 
  
 4.3.3. Sale Process. The Majority Carlyle Investors,
in the case of a proposed Sale pursuant to Section 4.2, or the Prospective Selling Stockholder, in the case of a proposed Sale pursuant to Section 4.1 shall, in their sole discretion, decide whether or not to pursue, consummate, postpone
or abandon any proposed Sale and the terms and conditions thereof. No Stockholder nor any Affiliate of any such holder shall have any liability to any other Stockholder or the Company arising from, relating to or in connection with the pursuit,
consummation, postponement, abandonment or terms and 

  

 -12- 

 
conditions of any proposed Sale except to the extent such holder shall have failed to comply with the provisions of this Section 4 and such failure
shall have had a materially adverse effect on such Stockholders’ ability to exercise its rights pursuant to Section 4.1 or 4.2, as applicable. 
  
 4.3.4. Treatment of Options, Warrants and Convertible Securities. If any Participating Seller shall Sell Options, Warrants or
Convertible Securities in any Sale pursuant to Section 4, such Participating Seller shall receive in exchange for such Options, Warrants or Convertible Securities consideration in the amount (if greater than zero) equal to the purchase price
received by the Prospective Selling Stockholder(s) in such Sale for the number of shares of each class of Stock that would be issued upon exercise, conversion or exchange of such Options, Warrants or Convertible Securities less the exercise price,
if any, of such Options, Warrants or Convertible Securities (to the extent exercisable, convertible or exchangeable at the time of such Sale), subject to reduction for any tax or other amounts required to be withheld under applicable law.

  
 4.3.5. Expenses. All reasonable costs
and expenses incurred by the Company in connection with any proposed Sale pursuant to Section 4.1, Section 4.2 or Section 4.4 (whether or not consummated), including all attorneys fees and charges, all accounting fees and charges and
all finders, brokerage or investment banking fees, charges or commissions, shall be paid by the Company. The Majority Carlyle Investors may retain, and the Company will pay the reasonable fees and expenses of, a single legal counsel (and such local
counsel as may be appropriate) to represent all Participating Sellers in connection with any proposed Sale pursuant to this Section 4 (whether or not consummated). Any other costs and expenses incurred by or on behalf of any or all of the
Participating Sellers in connection with any proposed Sale pursuant to this Section 4 (whether or not consummated) shall be borne by such Participating Seller(s). 
  
 4.3.6. Closing. The closing of a Sale to which Section 4.1, 4.2 or 4.4 applies shall take place
(i) on the proposed Transfer date, if any, specified in the Tag Along Notice, Drag Along Notice or Sale Notice, as applicable (provided that consummation of any Transfer may be extended beyond such date to the extent necessary to obtain any
applicable governmental approval or other required approval or to satisfy other conditions), (ii) if no proposed Transfer date was required to be specified in the Drag Along Notice, at such time as the Prospective Selling Stockholders shall
specify by notice to each Participating Seller and (iii) at such place as the Prospective Selling Stockholder(s) shall specify by notice to each Participating Seller in the case of a Sale to which Section 4.2 applies. At the closing of
such Sale, each Participating Seller shall deliver the certificates evidencing the Shares to be Sold by such Participating Seller, duly endorsed, or with stock (or equivalent) powers duly endorsed, for transfer with signature guaranteed, free and
clear of any liens or encumbrances, with any stock (or equivalent) transfer tax stamps affixed, against delivery of the applicable consideration. 
  
 4.4. Right of First Offer. If any Prospective Selling Stockholder proposes to Sell any Shares other than to a Permitted Transferee and before the
closing of an Initial Public Offering in a Transfer (including to another Stockholder or the Company or any of its subsidiaries) that is subject to Section 3.1.5: 
  

 -13- 

 4.4.1. Notice. The Prospective Selling Stockholder shall deliver a written notice
of such proposed Sale (a “Sale Notice”) to each other Stockholder (each, a “First Offer Holder”) (which notice may be the same notice as the Tag Along Notice delivered pursuant to Section 4.1) not less than
twenty Business Days prior to any such proposed Transfer. The Sale Notice shall include: 
  
 (i) (i) the number and class(es) of Shares proposed to be sold by the Prospective Selling Stockholder (the “Subject
Shares”), (ii) the per share purchase price or the formula by which such price is to be determined and (iii) the proposed Transfer date, if known; and 
  
 (ii) an invitation to each First Offer Holder to make an offer to purchase (subject to Section 4.4.6
below) any number of the Subject Shares at such price. 
  
 4.4.2. Exercise. 
  
 (i) Within
twenty Business Days after the date of delivery of the Sale Notice (the “First Offer Deadline”), each First Offer Holder may make an offer to purchase any number of the Subject Shares at the price set forth in the Sale Notice by
delivering a written notice (the “First Offer Notice”) of such offer specifying a number of Subject Shares offered to be purchased from the Prospective Selling Stockholder (each such Person delivering such notice, a “First
Offer Purchaser”). The receipt of consideration by any Prospective Selling Stockholder selling Shares in payment for the transfer of such Shares pursuant to this Section 4.4.2 shall be deemed a representation and warranty by such
Prospective Selling Stockholder that: (i) such Prospective Selling Stockholder has full right, title and interest in and to such Shares; (ii) such Prospective Selling Stockholder has all necessary power and authority and has taken all
necessary action to sell such Shares as contemplated by this Section 4.4.2; and (iii) such Shares are free and clear of any and all liens, encumbrances or other Adverse Claims. 
  
 (ii) Each Person not delivering a First Offer Notice that complies with the above requirements, including
the applicable time periods, shall be deemed to have waived all of such Person’s rights to purchase such Shares under this Section 4.4.2, and the Prospective Selling Stockholder shall thereafter be free to Sell the Subject Shares to the
First Offer Purchasers and/or any Prospective Buyer, at a per share purchase price no less than the price set forth in the Sale Notice, without any further obligation to such Person pursuant to this Section 4.4. 
  
 4.4.3. Irrevocable Offer. The offer of each First
Offer Purchaser contained in a First Offer Notice shall be irrevocable, and, subject to Section 4.4.6 below, to the extent such offer is accepted, such First Offer Purchaser shall be bound and obligated to purchase the number of Subject Shares
set forth in such First Offer Purchaser’s First Offer Notice. 
  
 4.4.4. Acceptance of Offers. Within five Business Days after the First Offer Deadline, the Prospective Selling Stockholder shall inform each First Offer Purchaser, by delivery of a written notice (the
“Acceptance Notice”), of whether or not the 

  

 -14- 

 
Prospective Selling Stockholder will accept all (but not less than all, subject to Section 4.4.6(ii)) offers of the First Offer Purchasers. In the event
the Prospective Selling Stockholder fails to deliver the Acceptance Notice within the specified time period, the Prospective Selling Stockholder shall be deemed to have decided not to Sell the Subject Shares to the First Offer Purchasers. If the
Prospective Selling Stockholder decides not to Sell the Subject Shares to the First Offer Purchasers, each First Offer Purchaser shall be released from such holder’s obligations under such holder’s irrevocable offer. Acceptance of such
offers by the Prospective Selling Stockholder is without prejudice to the Prospective Selling Stockholder’s discretion under Section 4.3.3 to determine whether or not to consummate any Sale. 
  
 4.4.5. Additional Compliance. If at the end of the
180th day after the date of delivery of the Sale Notice, the Prospective Selling Stockholder and First Offer Purchasers or Prospective Buyer (if not a First Offer Purchaser), if any, have not completed the Sale of the Subject Shares (other than due
to the failure of any First Offer Purchaser to perform its obligations under this Section 4.4), each First Offer Purchaser shall be released from such holder’s obligations under such holder’s irrevocable offer, the Sale Notice shall
be null and void, and it shall be necessary for a separate Sale Notice to be delivered, and the terms and provisions of this Section 4.4 separately complied with, in order to consummate a Transfer of such Subject Shares; provided,
however, that in the case of such a separate Sale Notice in which the classes of Subject Shares and the per share price are unchanged and the number of Subject Shares is substantially the same, the applicable period to which reference is made
in Section 4.4.1 and 4.4.2(i) shall be three Business Days and two Business Days, respectively. 
  
 4.4.6. Determination of the Number of Subject Shares to be Sold. 
  
 (i) In the event that the number of Shares offered to be purchased by the First Offer Purchasers is less
than the number of Subject Shares, (i) the Prospective Selling Stockholder may accept the offers of the First Offer Purchasers and, at the option of the Prospective Selling Stockholder, sell any remaining Subject Shares which the First Offer
Purchasers did not elect to purchase to one or more Prospective Buyers (subject to compliance with Section 4.1) at a price per share that is no less than the price set forth in the Sale Notice or (ii) if a single Prospective Buyer or group
of Prospective Buyers is unwilling to purchase less than all of the Subject Shares, the Prospective Selling Stockholder may Sell all (but not less than all) of the Subject Shares to such Prospective Buyer or group of Prospective Buyers at a price
per share that is no less than the price set forth in the Sale Notice rather than Sell the Subject Shares to the First Offer Purchasers (subject to compliance with Section 4.1). Such sales, if any, to Prospective Buyer(s) other than the First
Offer Purchasers in accordance with this clause (a) shall be consummated together with the sale to the First Offer Purchasers. 
  
 (ii) In the event that the aggregate number of Subject Shares offered to be purchased by (and to be sold to) the First Offer Purchasers is
equal to or exceeds the aggregate number of Subject Shares, the Prospective Selling Stockholder 

  

 -15- 

 
shall accept the offers of the First Offer Purchasers and the Subject Shares shall be sold to the First Offer Purchasers as follows: 
  

	 	(a)	there shall be first allocated to each First Offer Purchaser a number of Shares of each applicable class equal to the lesser of (X) the number of Shares of such class offered
to be purchased by such First Offer Purchaser pursuant such holder’s First Offer Notice, and (Y) a number of Shares of such class equal to such First Offer Purchaser’s Pro Rata Portion; and 

  

	 	(b)	the balance, if any, not allocated pursuant to clause (i) above shall be allocated to those First Offer Purchasers which offered to purchase a number of Shares of the
applicable class in excess of such Person’s Pro Rata Portion pro rata to each such First Offer Purchaser based upon the amount of such excess, or in such other manner as the First Offer Purchasers may otherwise agree. 

 
 In the event any holders of Shares exercise such holders’ rights
under Section 4.1 to sell Shares in connection with a Sale to First Offer Purchasers pursuant to this Section 4.4, such Shares (as the case may be, reduced in accordance with Section 4.1.4) shall be deemed to be Subject Shares for
purposes of this Section 4.4 and shall be allocated among the First Offer Purchasers in accordance with this 4.4.6. 
  
 4.5. Period. The provisions of Section 4.4 shall expire as to any Share on the earlier of (a) a Change of Control or (b) the Initial
Public Offering. Each of the other provisions of this Section 4 above shall expire upon a Change of Control. 
  
 5. RIGHT OF PARTICIPATION. The Company shall not, and shall not permit any direct or indirect subsidiary of the Company (the Company and each such subsidiary, an
“Issuer”) to, issue or sell any shares of any of its capital stock or any securities convertible into or exchangeable for any shares of its capital stock, issue or grant any options or warrants for the purchase of, or enter into any
agreements providing for the issuance (contingent or otherwise) of, any of its capital stock or any stock or securities convertible into or exchangeable for any shares of its capital stock, in each case, to any Person (each an
“Issuance” of “Subject Securities”), except in compliance with the provisions of this Section 5. 
  
 5.1. Right of Participation. 
  
 5.1.1. Offer. Not fewer than ten Business Days prior to the consummation of an Issuance, a notice (the “Participation
Notice”) shall be delivered by the Issuer to each Stockholder (the “Participation Offerees”). The Participation Notice shall include: 
  

(i) the principal terms and conditions of the proposed Issuance, including (i) he amount, kind and terms of the Subject Securities
to be included in the Issuance, (ii) the number of Equivalent Shares represented by such Subject Securities (if applicable), (iii) as to each Participation Offeree the number of Shares equal to the number of Equivalent Shares represented
by such Subject Securities multiplied by a fraction, the numerator of which is the aggregate number of Equivalent Shares of the applicable 

  

 -16- 

 
class held by such Participation Offeree and the denominator of which is the aggregate number of Equivalent Shares of the applicable class held by all
Participation Offerees (the “Participation Portion”), (iv) the maximum and minimum price (including if applicable, the maximum and minimum Price Per Equivalent Share) per unit of the Subject Securities, including a description
of any non-cash consideration sufficiently detailed to permit valuation thereof, (v) the proposed manner of disposition, (vi) the name and address of the Person to whom the Subject Securities will be issued (the “Prospective
Subscriber”) and (vii) if known, the proposed Issuance date; and 
  
 (ii) an offer by the Issuer to issue, at the option of each Participation Offeree, to such Participation Offeree such portion of the
Subject Securities to be included in the Issuance as may be requested by such Participation Offeree (not to exceed the Participation Portion of the total amount of Subject Securities to be included in the Issuance), on the same terms and conditions,
with respect to each unit of Subject Securities issued to the Participation Offerees, as each of the Prospective Subscribers shall be issued units of Subject Securities. 
  
 5.1.2. Exercise. 
  
 (i) General. Each Participation Offeree desiring to accept the offer contained in the Participation
Notice shall accept such offer by delivering a written notice of such acceptance to the Issuer within eight Business Days after the date of delivery of the Participation Notice specifying the amount of Subject Securities (not in any event to exceed
the Participation Portion of the total amount of Subject Securities to be included in the Issuance) which such Participation Offeree desires to be issued (each a “Participating Buyer”). Each Participation Offeree who does not accept
such offer in compliance with the above requirements, including the applicable time periods, shall be deemed to have waived all of such holder’s rights to participate in such Issuance, and the Issuer shall thereafter be free to issue Subject
Securities in such Issuance to the Prospective Subscriber and any Participating Buyers, at a price no less than the minimum price set forth in the Participation Notice and on other principal terms not substantially more favorable to the Prospective
Subscriber than those set forth in the Participation Notice, without any further obligation to such non-accepting Participation Offerees pursuant to Section 5. If, prior to consummation, the terms of such proposed Issuance shall change with the
result that the price shall be less than the minimum price set forth in the Participation Notice or the other principal terms shall be substantially more favorable to the Prospective Subscriber than those set forth in the Participation Notice, it
shall be necessary for a separate Participation Notice to be delivered, and the terms and provisions of this Section 5.1 separately complied with, in order to consummate such Issuance pursuant to this Section 5.1; provided,
however, that in such case of a separate Participation Notice, the applicable period to which reference is made in Section 5.1.1 and in the first sentence of Section 5.1.2(i) shall be three Business Days and two Business Days,
respectively. 
  
 (ii) Irrevocable
Acceptance. The acceptance of each Participating Buyer shall be irrevocable except as hereinafter provided, and each such Participating Buyer shall be bound and obligated to acquire in the Issuance on the same terms and conditions, with 

  

 -17- 

 
respect to each unit of Subject Securities issued, as the Prospective Subscriber, such amount of Subject Securities as such Participating Buyer shall have
specified in such Participating Buyer’s written commitment. 
  
 (iii) Time Limitation. If at the end of the 180th day after the date of the effectiveness of the Participation Notice the Issuer has not completed the Issuance, each Participating Buyer shall be released from
such holder’s obligations under the written commitment, the Participation Notice shall be null and void, and it shall be necessary for a separate Participation Notice to be delivered, and the terms and provisions of this Section 5.1
separately complied with, in order to consummate such Issuance pursuant to this Section 5.1; provided, however, that in such case of a separate Participation Notice on substantially the same terms and conditions, the applicable
period to which reference is made in Section 5.1.1 and in the first sentence of Section 5.1.2(i) shall be three Business Days and two Business Days, respectively. 
  
 5.1.3. Other Securities. The Issuer may condition the participation of the Participation Offerees in
an Issuance upon the purchase by such Participation Offerees of any securities (including debt securities) other than Subject Securities (“Other Securities”) in the event that the participation of the Prospective Subscriber in such
Issuance is so conditioned. In such case, each Participating Buyer shall acquire in the Issuance, together with the Subject Securities to be acquired by it, Other Securities in the same proportion to the Subject Securities to be acquired by it as
the proportion of Other Securities to Subject Securities being acquired by the Prospective Subscriber in the Issuance, on the same terms and conditions, as to each unit of Subject Securities and Other Securities issued to the Participating Buyers,
as the Prospective Subscriber shall be issued units of Subject Securities and Other Securities. 
  
 5.1.4. Certain Legal Requirements. In the event that the participation in the Issuance by a Participation Offeree as a
Participating Buyer would require under applicable law (i) the registration or qualification of such securities or of any Person as a broker or dealer or agent with respect to such securities where such registration or qualification is not
otherwise required for the Issuance or (ii) the provision to any participant in the Sale of any specified information regarding the Company or any of its subsidiaries or the securities that is not otherwise required to be provided for the
Issuance, such Participation Offeree shall not have the right to participate in the Issuance. Without limiting the generality of the foregoing, it is understood and agreed that neither the Company nor the Issuer shall be under any obligation to
effect a registration of such securities under the Securities Act or similar state statutes. 
  
 5.1.5. Further Assurances. Each Participating Buyer shall take or cause to be taken all such reasonable actions as may be necessary
or reasonably desirable in order expeditiously to consummate each Issuance pursuant to this Section 5.1 and any related transactions, including executing, acknowledging and delivering consents, assignments, waivers and other documents or
instruments; filing applications, reports, returns, filings and other documents or instruments with governmental authorities; and otherwise cooperating with the Issuer and the Prospective Subscriber. Without limiting the generality of the foregoing,
each such Participating Buyer agrees to execute and deliver 

  

 -18- 

 
such subscription and other agreements specified by the Issuer to which the Prospective Subscriber will be party. 
  
 5.1.6. Expenses. All costs and expenses incurred by
the Issuer in connection with any proposed Issuance of Subject Securities (whether or not consummated), including all attorney’s fees and charges, all accounting fees and charges and all finders, brokerage or investment banking fees, charges or
commissions, shall be paid by the Company or the Issuer. The Majority Carlyle Investors may retain, and the Company will pay the reasonable fees and expenses of, a single legal counsel (and such local counsel as may be appropriate) to represent all
Prospective Subscribers in connection with such proposed Issuance of Subject Securities (whether or not consummated). Any other costs and expenses incurred by or on behalf of any Stockholder in connection with such proposed Issuance of Subject
Securities (whether or not consummated) shall be borne by such holder. 
  
 5.1.7. Closing. The closing of an Issuance pursuant to Section 5.1 shall take place (i) on the proposed date of Issuance, if any, set forth in the Participation Notice (provided that consummation of
any Transfer may be extended beyond such date to the extent necessary to obtain any applicable governmental approval or other required approval or to satisfy other conditions), (ii) if no proposed Transfer date was required to be specified in
the Participation Notice, at such time as the Issuer shall specify by notice to each Participating Buyer, provided that such closing with respect to a Participating Buyer shall not (without the consent of such Participating Buyer) be prior to
the date that is ten Business Days after the Company issues the applicable Participation Notice and (iii) at such place as the Issuer shall specify by notice to each Participating Buyer. At the closing of any Issuance under this
Section 5.1.7, each Participating Buyer shall be delivered the notes, certificates or other instruments evidencing the Subject Securities (and, if applicable, Other Securities) to be issued to such Participating Buyer, registered in the name of
such Participating Buyer or such holder’s designated nominee, free and clear of any liens or encumbrances, with any transfer tax stamps affixed, against delivery by such Participating Buyer of the applicable consideration. 
  
 5.2. Post-Issuance Notice. Notwithstanding the requirements of
Section 5.1, the Issuer may proceed with any Issuance prior to having complied with the provisions of Section 5.1; provided that the Issuer shall: 
  
 (a) provide to each Investor who would have been a Participation Offeree in connection with such Issuance
(i) with prompt notice of such Issuance and (ii) the Participation Notice described in Section 5.1.1 in which the actual price per unit of Subject Securities (and, if applicable, actual Price Per Equivalent Share) shall be set forth;

  
 (b) offer to issue to such Investor such
number of securities of the type issued in the Issuance as may be requested by such Investor (not to exceed the Participation Portion that such Investor would have been entitled to pursuant to Section 5.1 multiplied by the sum of (a) the
number of Subject Securities included 

  

 -19- 

 
in the Issuance and (b) the aggregate number of shares issued pursuant to this Section 5.2 with respect to such Issuance) on the same economic
terms and conditions with respect to such securities as the subscribers in the Issuance received; and 
  
 (c) keep such offer open for a period of ten Business Days, during which period, each such Investor may accept such offer by sending a
written acceptance to the Issuer committing to purchase an amount of such securities (not in any event to exceed the Participation Portion that such holder would have been entitled to pursuant to Section 5.1 multiplied by the sum of
(a) the number of Subject Securities included in such issuance and (b) the aggregate number of shares issued pursuant to this Section 5.2 with respect to such Issuance). 
  
 5.3. Excluded Transactions. The provisions of this Section 5 shall not apply to Issuances by the Company or any
subsidiary of the Company as follows: 
  
 (a) Any
Issuance of Stock upon the exercise or conversion of any Stock, Options, Warrants or Convertible Securities outstanding on the date hereof or Issued after the date hereof in compliance with the provisions of this Section 5; 
  
 (b) Any Issuance of shares of Stock, Options, Warrants or
Convertible Securities, in each case to the extent approved by the Majority Carlyle Investors, to officers, employees, directors or consultants of the Company or its subsidiaries in connection with such Person’s employment or consulting
arrangements with the Company or its subsidiaries; 
  
 (c) Any Issuance of shares of Stock, Options, Warrants or Convertible Securities, in each case to the extent approved by the Majority Carlyle Investors, (i) in any business combination or acquisition transaction involving the Company
or any of its subsidiaries or (ii) in connection with any joint venture or strategic partnership; 
  
 (d) Any Issuance of Stock pursuant to an Initial Public Offering; 
  
 (e) The Issuance of Shares to the Investors in connection with the Closing; 
  
 (f) Any Issuance of shares of Stock in connection with any
stock split, stock dividend or recapitalization approved by the Majority Carlyle Investors; 
  
 (g) Any Issuance of shares of Stock in exchange for debt securities; or 
  
 (h) Any Issuance by a subsidiary to the Company or a wholly-owned subsidiary of the Company. 
  
 5.4. Certain Provisions Applicable to Options, Warrants and Convertible
Securities. In the event that the Issuance of Subject Securities shall result in any increase in the number of shares of Stock issuable upon exercise, conversion or exchange of any Options, Warrants or 

  

 -20- 

 
Convertible Securities, the number of shares (or Equivalent Shares, if applicable) of Subject Securities (and Other Securities, if applicable) which the
holders of such Options, Warrants or Convertible Securities, as the case may be, shall be entitled to purchase pursuant to Section 5.1, if any, shall be reduced, share for share, by the amount of any such increase. 
  
 5.5. Acquired Shares. Any Subject Securities constituting Stock
acquired by any Stockholder pursuant to this Section 5 shall be deemed for all purposes hereof to be Shares hereunder. 
  
 5.6. Period. Each of the foregoing provisions of this Section 5 shall expire on the earlier of (a) a Change of Control or (b) the
closing of the Initial Public Offering. 
  
 6. COVENANTS. 
  
 6.1. Information Rights. 
  
 6.1.1. Historical Financial Information. The Company
will furnish to each Stockholder the following: 
  
 (a) As soon as available, and in any event within 120 days after the end of each fiscal year of the Company, the consolidated balance sheet of the Company and its subsidiaries as at the end of each such fiscal year and the consolidated
statements of income, cash flows and changes in stockholders’ equity for such year of the Company and its subsidiaries, setting forth in each case in comparative form the figures for the next preceding fiscal year, accompanied by the report of
independent certified public accountants of recognized national standing, to the effect that, except as set forth therein, such consolidated financial statements have been prepared in accordance with generally accepted accounting principles applied
on a basis consistent with prior years and fairly present in all material respects the financial condition of the Company and its subsidiaries at the dates thereof and the results of their operations and changes in their cash flows and
stockholders’ equity for the periods covered thereby. 
  
 (b) As soon as available, and in any event within 60 days after the end of each fiscal quarter of the Company, the consolidated balance sheet of the Company and its subsidiaries as at the end of such quarter and the
consolidated statements of income, cash flows and changes in stockholders’ equity for such quarter and the portion of the fiscal year then ended of the Company and its subsidiaries, setting forth in each case the figures for the corresponding
periods of the previous fiscal year in comparative form, all in reasonable detail. 
  
 (c) As soon as available, and in any event within 25 days after the end of each month, the consolidated balance sheet of the Company and
its subsidiaries as at the end of such month and the consolidated statements of income, cash flows for such month and the portion of the fiscal year then ended of the Company and its subsidiaries (to the extent prepared by the Company), setting
forth in each case the figures for the corresponding periods of the previous fiscal year in comparative form, all in reasonable detail. 
  

 -21- 

 6.1.2. Period. Each of the foregoing provisions of this Section 6.1 shall
expire on the earlier of (a) a Change of Control or (b) the closing of the Initial Public Offering. 
  
 6.2. Confidentiality. Each Stockholder agrees that it will keep confidential and will not disclose, divulge or use for any purpose, other than to
monitor its investment in the Company and its subsidiaries, any confidential information obtained from the Company pursuant to the terms of this Agreement, unless such confidential information (i) is known or becomes known to the public in
general (other than as a result of a breach of this Section 6.2 by such Stockholder or its Affiliates), (ii) is or has been independently developed or conceived by such Stockholder without use of the Company’s confidential information
or (iii) is or has been made known or disclosed to such Stockholder by a third party (other than an Affiliate of such Stockholder) without a breach of any obligation of confidentiality such third party may have to the Company that is known to
such Stockholder; provided, however, that a Stockholder may disclose confidential information (a) to its attorneys, accountants, and investment bankers to the extent necessary to obtain their services in connection with monitoring
its investment in the Company provided that such attorneys, accountants and investment bankers agree to be bound by the provisions of this Section 6.2, (b) to any prospective purchaser of any Shares from such Stockholder provided that such
prospective purchaser agrees to be bound by the provisions of this Section 6.2, (c) to any Affiliate, partner or member of such Stockholder in the ordinary course of business, or (d) as may otherwise be required by law,
provided that such Stockholder takes reasonable steps to minimize the extent of any such required disclosure; and provided, further, however, that the acts and omissions of any Person to whom such Stockholder may disclose
confidential information pursuant to clauses (a) through (c) of the preceding proviso shall be attributable to such Stockholder for purposes of determining such Stockholder’s compliance with this Section 6.2. Each of the parties
hereto acknowledge that the Investors may review the business plans and related proprietary information of many enterprises, including enterprises which may have products or services which compete directly or indirectly with those of the Company.
Nothing in this Section 6.2 shall preclude or in any way restrict the Investors or their Affiliates from investing or participating in any particular enterprise, or trading in the securities thereof, whether or not such enterprise has products
or services that compete with those of the Company. 
  
 7. REMEDIES.

  
 7.1. Generally. The parties shall have all remedies
available at law, in equity or otherwise in the event of any breach or violation of this Agreement or any default hereunder. The parties acknowledge and agree that in the event of any breach of this Agreement, in addition to any other remedies which
may be available, each of the parties hereto shall be entitled to specific performance of the obligations of the other parties hereto and, in addition, to such other equitable remedies (including preliminary or temporary relief) as may be
appropriate in the circumstances. 
  
 7.2. Deposit. Without
limiting the generality of Section 7.1, if any Stockholder fails to deliver to the purchaser thereof the certificate or certificates evidencing Shares to be Sold pursuant to Section 4, such purchaser may, at its option, in addition to all
other remedies it may have, deposit the purchase price for such Shares with any national bank or trust company having combined capital, surplus and undivided profits in excess of One Hundred Million Dollars 

  

 -22- 

 
($100,000,000) (the “Escrow Agent”), and the Company shall cancel on its books the certificate or certificates representing such Shares and
thereupon all of such holder’s rights in and to such Shares shall terminate. Thereafter, upon delivery to such purchaser by such holder of the certificate or certificates evidencing such Shares (duly endorsed, or with stock powers duly
endorsed, for transfer, with signature guaranteed, free and clear of any liens or encumbrances, and with any transfer tax stamps affixed), such purchaser shall instruct the Escrow Agent to deliver the purchase price (without any interest from the
date of the closing to the date of such delivery, any such interest to accrue to such purchaser) to such holder. 
  
 8. LEGENDS. 
  
 8.1. Restrictive Legend. Each certificate representing Shares shall have the following legend endorsed conspicuously thereupon: 
  
 “THE VOTING OF THE SHARES OF STOCK REPRESENTED BY THIS CERTIFICATE,
AND THE SALE, ENCUMBRANCE OR OTHER DISPOSITION THEREOF, ARE SUBJECT TO THE PROVISIONS OF A STOCKHOLDERS AGREEMENT TO WHICH THE ISSUER AND CERTAIN OF ITS STOCKHOLDERS ARE PARTY. THE SHARES OF STOCK REPRESENTED BY THIS CERTIFICATE ARE ENTITLED TO
CERTAIN REGISTRATION RIGHTS AS PROVIDED FOR IN A REGISTRATION RIGHTS AGREEMENT TO WHICH THE ISSUER AND CERTAIN OF ITS STOCKHOLDERS ARE PARTY, WHICH REGISTRATION RIGHTS MAY NOT BE TRANSFERRED EXCEPT AS PROVIDED FOR IN THE REGISTRATION RIGHTS
AGREEMENT. A COPY OF THE STOCKHOLDERS AGREEMENT AND THE REGISTRATION RIGHTS MAY BE INSPECTED AT THE PRINCIPAL OFFICE OF THE ISSUER OR OBTAINED FROM THE ISSUER WITHOUT CHARGE.” 
  
 Any Person who acquires Shares which are not subject to all or part of the terms of this Agreement shall have the right to
have such legend (or the applicable portion thereof) removed from certificates representing such Shares. 
  
 8.2. 1933 Act Legends. Each certificate representing Shares shall have the following legend endorsed conspicuously thereupon: 
  
 “THE SECURITIES REPRESENTED BY THIS CERTIFICATE WERE ISSUED IN A
PRIVATE PLACEMENT, WITHOUT REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND MAY NOT BE SOLD, ASSIGNED, PLEDGED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION UNDER THE ACT 

  

 -23- 

 
COVERING THE TRANSFER OR AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE ISSUER, THAT REGISTRATION UNDER THE ACT IS NOT REQUIRED.”

  
 8.3. Stop Transfer Instruction. The Company will
instruct any transfer agent not to register the Transfer of any Shares until the conditions specified in the foregoing legends and this Agreement are satisfied. 
  

8.4. Termination of 1933 Act Legend. The requirement imposed by Section 8.2 hereof shall cease and terminate as to any particular Shares
(a) when, in the opinion of counsel reasonably acceptable to the Company, such legend is no longer required in order to assure compliance by the Company with the Securities Act or (b) when such Shares have been effectively registered under
the Securities Act or transferred pursuant to Rule 144. Wherever (x) such requirement shall cease and terminate as to any Shares or (y) such Shares shall be transferable under paragraph (k) of Rule 144, the holder thereof shall be
entitled to receive from the Company, as the case may be, without expense, new certificates not bearing the legend set forth in Section 8.2 hereof. 
  
 9. AMENDMENT, TERMINATION, ETC. 
  
 9.1. Oral Modifications. This Agreement may not be orally amended, modified, extended or terminated, nor shall any oral waiver of any of its terms
be effective. 
  
 9.2. Written Modifications. This
Agreement may be amended, modified, extended or terminated, and the provisions hereof may be waived, only by an agreement in writing signed by the Company and the Majority Carlyle Investors; provided, however, that the consent of any
party shall be required for any Amendment that discriminates against such party. Each such Amendment shall be binding upon each party hereto and each Stockholder subject hereto. In addition, each party hereto and each Stockholder subject hereto may
waive any right hereunder by an instrument in writing signed by such party or holder. To the extent the Amendment of any Section of this Agreement would require a specific consent pursuant to this Section 9.2, any Amendment to the definitions
used in such Section shall also require the specified consent. 
  
 9.3. Effect of Termination. No termination under this Agreement shall relieve any Person of liability for breach prior to termination. 
  
 10. DEFINITIONS. For purposes of this Agreement: 
  
 10.1. Certain Matters of Construction. In addition to the definitions referred to or set forth below in this Section 10: 
  
 (i) The words “hereof’, “herein”,
“hereunder” and words of similar import shall refer to this Agreement as a whole and not to any particular Section or provision of this Agreement, and reference to a particular Section of this Agreement shall include all subsections
thereof; 
  
 (ii) The word “including”
shall mean including, without limitation; 
  

 -24- 

 (iii) Definitions shall be equally applicable to both nouns and verbs and the singular
and plural forms of the terms defined; and 
  
 (iv) The masculine, feminine and neuter genders shall each include the other. 
  
 10.2. Definitions. The following terms shall have the following meanings: 
  
 “Acceptance Notice” shall have the meaning set forth in Section 4.4.4. 
  
 “Acquisition” shall have the meaning set forth in the Recitals. 
  
 “Acquisition Agreement” shall have the meaning set forth in
the Recitals. 
  
 “Adverse Claim” shall have the
meaning set forth in Section 8-102 of the applicable Uniform Commercial Code. 
  
 “Affiliate” shall mean, with respect to any specified Person, (a) any other Person which directly or indirectly through one or more intermediaries controls, or is controlled by, or is under
common control with, such specified Person (for the purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control with”), as
used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or
otherwise); provided, however, that neither the Company nor any of its subsidiaries shall be deemed an Affiliate of any of the Stockholders (and vice versa), (b) if such specified Person is an investment fund, in addition to the
Persons identified in clause (a), any other investment fund the primary investment advisor to which is the primary investment advisor to such specified Person or an Affiliate thereof, and (c) if such specified Person is a natural Person, in
addition to the Persons identified in clause (a), any Family Member of such natural Person. 
  
 “Affiliated Fund” shall mean, with respect to any specified Person, an investment fund that is an Affiliate of such Person or an entity that is directly or indirectly wholly-owned by such Investor or
one or more of such funds (other than a portfolio company of any such fund). 
  
 “Agreement” shall have the meaning set forth in the Preamble. 
  
 “Amendment” shall have the meaning set forth in Section 9.2. 
  
 “Board” shall mean the board of directors of the Company. 
  
 “Business Day” shall mean any day that is not a Saturday, a
Sunday or other day on which banks are required or authorized by law to be closed in the City of New York. 
  
 “Carlyle Investors” shall mean, as of any date, Carlyle Partners IV and Carlyle Partners IV Coinvestment, L.P. and their respective
Permitted Transferees, in each case only if such Person then holds Shares. 
  

 -25- 

 “Carlyle Partners IV” means, as of any date, Carlyle Partners IV, L.P., a Delaware
limited partnership. 
  
 “Change of Control”
shall mean the occurrence hereafter of any of the following: 
  
 (a) the sale, lease or transfer, in one or a series of related transactions, of all or substantially all of the assets of the Company and its direct and indirect subsidiaries, taken as a whole, to any Person other
than one or more Permitted Holders; 
  
 (b) the
Board’s adoption of a plan relating to the liquidation or dissolution of the Company; 
  
 (c) the acquisition by (x) any Person (other than one or more Permitted Holders) or (y) any Persons (other than one or more
Permitted Holders) that together (A) are a group (within the meaning of Section 13(d)(3), Section 14(d)(2) of the Exchange Act, or any successor provision) or (B) are acting, for purposes of acquiring, holding or disposing of
securities, as a group (within the meaning of Rule 13d-5(b)(1) of the Exchange Act, or any successor provision), in a single transaction or in a related series of transactions, by way of merger, consolidation or other business combination or
purchase of beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act, or any successor provision) of 40% or more of the total voting power of the Common Stock of the Company; or 
  
 (d) the first day on which a majority of the members of the
Board cease to be Continuing Directors. 
  
 “Closing” shall have the meaning set forth in Section 1.1. 
  
 “Commission” shall mean the Securities and Exchange Commission. 
  
 “Common Stock” shall mean the common stock of the Company, par value $.01 per share. 
  
 “Company” shall have the meaning set forth in the Preamble.

  
 “Continuing Director” means, as of any date
of determination, any member of the Board who (1) was a member of the Board immediately following the closing on August 11, 2005; (2) was nominated for election or elected to such Board with the approval of a majority of the
Continuing Directors who were members of such Board at the time of such nomination or election; or (3) was designated or appointed by TC Group, L.L.C. (which operates under the trade name “The Carlyle Group”) or any of its Affiliates.

  
 “Convertible Securities” shall mean any
evidence of indebtedness, shares of stock (other than Stock) or other securities (other than Options and Warrants) which are directly or indirectly convertible into or exchangeable or exercisable for shares of Stock. 
  
 “Drag Along Notice” shall have the meaning set forth in
Section 4.2.1. 
  

 -26- 

 “Drag Along Sale Percentage” shall have the meaning set forth in Section 4.2.

  
 “Drag Along Sellers” shall have the meaning
set forth in Section 4.2.1. 
  
 “Equivalent
Shares” shall mean, at any date of determination, (a) as to any outstanding shares of Stock issued to or held by any Stockholder other than a Manager, such number of shares of Stock, (b) as to any outstanding Options, Warrants or
Convertible Securities which constitute Shares, the maximum number of shares of Stock for which or into which such Options, Warrants or Convertible Securities may at the time be exercised, converted or exchanged (or which will become exercisable,
convertible or exchangeable on or prior to, or by reason of, the transaction or circumstance in connection with which the number of Equivalent Shares is to be determined) and (c) as to any outstanding shares of Stock issued to or held by a
Manager, such portion of such shares as are Purchased Shares or Vested Incentive Shares. 
  
 “Escrow Agent” shall have the meaning set forth in Section 7.2. 
  
 “Exchange Act” shall mean the Securities Exchange Act of 1934, as in effect from time to time. 
  
 “Fair Market Value” shall mean, as of any date, as to any
Share, the Board’s good faith determination of the fair value of such Share as of the applicable reference date. 
  
 “Family Member” shall mean, with respect to any natural Person, (i) any lineal descendant or ancestor or sibling (by birth or
adoption) of such natural Person, (ii) any spouse or former spouse of any of the foregoing, (iii) any legal representative or estate of any of the foregoing and (iv) any trust maintained for the benefit of the foregoing. 

 
 “First Offer Deadline” shall have the meaning set forth
in Section 4.4.1(i). 
  
 “First Offer
Holder” shall have the meaning set forth in Section 4.4.1. 
  
 “First Offer Notice” shall have the meaning set forth in Section 4.4.2(i) . 
  
 “First Offer Purchaser” shall have the meaning set forth in Section 4.4.1(i). 
  
 “Holdco” shall have the meaning set forth in the Preamble.

  
 “Initial Public Offering” shall mean the
initial Public Offering registered on Form S-1 (or any successor form under the Securities Act). 
  
 “Initiating Investor” shall have the meaning set forth in the Registration Rights Agreement. 
  
 “Investors” shall have the meaning set forth in the
Preamble. 
  
 “Issuance” shall have the meaning
set forth in Section 5. 
  
 “Issuer” shall
have the meaning set forth in Section 5. 
  

 -27- 

 “LifeCare” shall have the meaning set forth in the Recitals. 
  
 “Majority Carlyle Investors” shall mean, as of any date, the
holders of a Majority in Interest of the Shares held by the Carlyle Investors. 
  
 “Majority in Interest” shall mean, (a) with respect to a set of Shares of a single class, a majority of such Shares and (b) with respect to a set of Shares of more than one class, a majority
in aggregate Purchase Price Value of such Shares. 
  
 “Manager” shall have the meaning set forth in the Recitals. 
  
 “Merger Sub.” shall have the meaning set forth in the Preamble. 
  
 “Midco” shall have the meaning set forth in the Preamble. 
  
 “Options” shall mean any options to subscribe for, purchase or otherwise directly acquire Stock, other than
any such option held by the Company or any right to purchase shares pursuant to this Agreement. 
  
 “Other Securities” shall have the meaning set forth in Section 5.1.3. 
  
 “Participating Buyer” shall have the meaning set forth in Section 5.1.2(i). 
  
 “Participating Seller” shall have the meaning set forth in
Section 4.1.2 and 4.2.1. 
  
 “Participation
Notice” shall have the meaning set forth in Section 5.1.1. 
  
 “Participation Offerees” shall have the meaning set forth in Section 5.1.1. 
  
 “Participation Portion” shall have the meaning set forth in Section 5.1.2(i). 
  
 “Permitted Holders” means (i) TC Group, L.L.C., Carlyle
Partners IV, L.P. and CP IV Coinvestment, L.P. and their Affiliates (but excluding any portfolio companies of the foregoing) and (ii) any members of the management of the Company immediately following the closing on August 11, 2005.

  
 “Permitted Transferee” shall mean (a) in
respect of any Investor, any Affiliated Fund of such Investor and (b) in respect of any Manager, any Family Member of such Manager, in each case to the extent such Person agrees to be bound by the terms of this Agreement in accordance with
Section 3.2 (if not already bound hereby). In addition, any Stockholder shall be a Permitted Transferee of the Permitted Transferees of itself. 
  
 “Person” shall mean any individual, partnership, corporation, company, association, trust, joint venture, limited liability company,
unincorporated organization, entity or division, or any government, governmental department or agency or political subdivision thereof. 
  
 “Price Per Equivalent Share” shall mean the Board’s good faith determination of the price per Equivalent Share of any Convertible
Securities or Options which are the subject of an Issuance pursuant to Section 5 hereof. 
  

 -28- 

 “Pro Rata Portion” shall mean: 
  
 (i) for purposes of Section 4.1.4 with respect to each
Tag Along Seller, a number of Equivalent Shares equal to the aggregate number of Shares of the applicable class that the Prospective Buyer is willing to purchase in the proposed Sale, multiplied by a fraction, the numerator of which is the aggregate
number of Equivalent Shares of the applicable class held by such Tag Along Seller and the denominator of which is equal to the aggregate number of Equivalent Shares of the applicable class held by all Tag Along Sellers; and 
  
 (ii) for purposes of Section 4.4.6, with respect to
each First Offer Purchaser, a number of Shares equal to the aggregate number of Subject Shares of the applicable class multiplied by a fraction, the numerator of which is the aggregate number of Equivalent Shares of the applicable class held by such
First Offer Purchaser and the denominator of which is the aggregate number of Equivalent Shares of the applicable class held by all First Offer Purchasers. 
  
 “Prospective Buyer” shall mean any Person, including the Company or any of its subsidiaries, proposing to purchase or otherwise acquire
shares from a Prospective Selling Stockholder. 
  
 “Prospective Selling Stockholder” shall mean: 
  
 (i) for purposes of Section 3.4, any Stockholder that proposes to Transfer any Shares to any Prospective Buyer; 
  
 (ii) for purposes of Section 4.1, any Stockholder that proposes to Transfer any Shares to any Prospective Buyer, including a First
Offer Purchaser pursuant to Section 4.4; 
  
 (iii) for purposes of Section 4.2, any Stockholder forming part of the acting Majority Carlyle Investors that has elected to exercise the drag along right provided by such Section; and 
  
 (iv) for purposes of Section 4.4, any Stockholder that
proposes to Transfer any Shares in a transaction that is subject to such Section. 
  
 “Prospective Subscriber” shall have the meaning set forth in Section 5.1.1(i). 
  
 “Public Offering” shall mean a public offering and sale of Common Stock for cash pursuant to an effective registration statement under
the Securities Act. 
  
 “Purchase Price Value”
shall mean: $10.00 in the case of each share of Common Stock, appropriately adjusted for any stock split, stock dividend, combination, recapitalization or the like involving such class. 
  

 -29- 

 “Purchased Shares” shall mean all shares of Stock held by a Manager that were purchased
by the original holder thereof in connection with the Closing or subsequent thereto, whether upon exercise of an Option or otherwise. 
  
 “Rule 144” shall mean Rule 144 under the Securities Act (or any successor Rule). 
  
 “Sale” shall mean a Transfer for value and the terms
“Sell” and “Sold” shall have correlative meanings. 
  
 “Sale Notice” shall have the meaning set forth in Section 4.4.1. 
  
 “Securities Act” shall mean the Securities Act of 1933, as in effect from time to time. 
  
 “Shares” shall mean (a) all shares of Stock held by a
Stockholder, whenever issued, including all shares of Stock issued upon the exercise, conversion or exchange of any Options, Warrants or Convertible Securities and (b) all Options, Warrants and Convertible Securities held by a Stockholder
(treating such Options, Warrants and Convertible Securities as a number of Shares equal to the number of Equivalent Shares represented by such Options, Warrants and Convertible Securities for all purposes of this Agreement except as otherwise
specifically set forth herein). 
  
 “Stock” shall
mean the Common Stock. 
  
 “Stockholders” shall
have the meaning set forth in the Preamble. 
  
 “Strategic
Investor” shall mean, with respect to any proposed Transfer, any (a) Person that is determined by the Carlyle Majority Investors to be a competitor of the Company or any of its subsidiaries in any material respect or a potential
strategic investor in the Company or any of its subsidiaries and (b) any Affiliate of any such Person specified in clause (a). 
  
 “Subject Securities” shall have the meaning set forth in Section 5. 
  
 “Subject Shares” shall have the meaning set forth in Section 4.4(a). 
  
 “Subscription Agreement” shall have the meaning set forth in
Section 11.3. 
  
 “Tag Along Deadline” shall
have the meaning set forth in Section 4.1.2. 
  
 “Tag
Along Holder” shall have the meaning set forth in Section 4.1.1. 
  
 “Tag Along Notice” shall have the meaning set forth in Section 4.1.1. 
  
 “Tag Along Offer” shall have the meaning set forth in Section 4.1.2. 
  
 “Tag Along Sale Percentage” shall have the meaning set forth in Section 4.1.1(a). 
  
 “Tag Along Sellers” shall have the meaning set forth in
Section 4.1.2. 
  

 -30- 

 “Transfer” shall mean any sale, pledge, assignment, encumbrance or other transfer or
disposition of any Shares to any other Person, whether directly, indirectly, voluntarily, involuntarily, by operation of law, pursuant to judicial process or otherwise. 
  
 “Vested Incentive Shares” shall mean, with respect to a Manager at any time, the shares of Stock and
Options held by such Manager that are not Purchased Shares (treating such Options as a number of Incentive Shares equal to the maximum number of shares of Stock for which such Options may at the time be exercised) which are fully vested at such
time. 
  
 “Warrants” shall mean any warrants to
subscribe for, purchase or otherwise directly acquire Stock. 
  
 11.
MISCELLANEOUS. 
  
 11.1. Authority: Effect. Each party
hereto represents and warrants to and agrees with each other party that the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized on behalf of such party and do not violate
any agreement or other instrument applicable to such party or by which its assets are bound. This Agreement does not, and shall not be construed to, give rise to the creation of a partnership among any of the parties hereto, or to constitute any of
such parties members of a joint venture or other association. 
  
 11.2. Notices. All notices, requests, demands, claims and other communications required or permitted to be delivered, given or otherwise provided under this Agreement must be in writing and must be delivered, given or otherwise
provided: 
  
 (a) by hand (in which case, it will
be effective upon delivery); 
  
 (b) by facsimile
(in which case, it will be effective upon receipt of confirmation of good transmission); or 
  
 (c) by overnight delivery by a nationally recognized courier service (in which case, it will be effective on the Business Day after being
deposited with such courier service); 
  

 -31- 

 in each case, to the address (or facsimile number) listed below: 
  
 If to the Company, Midco, Holdco or Merger Sub., to it: 
  
 c/o LifeCare Holdings, Inc. 
 4460 Tennyson Parkway 
 Plano, TX 75024

 Facsimile: (469) 241-2199 
 Attention: Legal Department 
  
 with copies to:

  
 Ropes & Gray LLP 
 One International Place 
 Boston,
Massachusetts 02110 
 Facsimile: (617) 951-7050 

			
	Attention:	 	 William A. Knowlton
 R. Newcomb Stillwell

Craig E. Marcus

  
 If to a Carlyle
Investor, to it: 
  
 c/o The Carlyle Group 
 520 Madison Avenue, 42nd Floor 
 New York, New York 10022 
 Facsimile: (212) 381-4901 

			
	Attention:	 	 W. Robert Dahl
 Walter S. Jin
 Eric Edell

  
 with copies to:

  
 Ropes & Gray LLP 
 One International Place 
 Boston,
Massachusetts 02110 
 Facsimile: (617) 951-7050 

			
	Attention:	 	 William A. Knowlton
 R. Newcomb Stillwell

Craig E. Marcus

  
 Notice to the holder
of record of any shares of capital stock shall be deemed to be notice to the holder of such shares for all purposes hereof. Each of the parties to this Agreement may specify a different address or facsimile number by giving notice in accordance with
this Section 11.2 to each of the other parties hereto, provided, however, that any such notice of change of address shall be effective only upon receipt. 
  
 11.3. Binding Effect, Etc. This Agreement constitutes the entire agreement of the parties with respect to its subject
matter, supersedes all prior or contemporaneous oral or written 

  

 -32- 

 
agreements or discussions with respect to such subject matter, and shall be binding upon and inure to the benefit of the parties hereto and their respective
heirs, representatives, successors and permitted assigns. Except as otherwise expressly provided herein, no holder party hereto may assign any of its respective rights or delegate any of its respective obligations under this Agreement without the
prior written consent of the other parties hereto, and any attempted assignment or delegation in violation of the foregoing shall be null and void. 
  
 11.4. Descriptive Heading. The descriptive headings of this Agreement are for convenience of reference only, are not to be considered a part hereof
and shall not be construed to define or limit any of the terms or provisions hereof. 
  
 11.5. Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original, but all of which taken together shall constitute one instrument. 
  
 11.6. Severability. In the event that any provision hereof would,
under applicable law, be invalid or unenforceable in any respect, such provision shall be construed by modifying or limiting it so as to be valid and enforceable to the maximum extent compatible with, and possible under, applicable law. The
provisions hereof are severable, and in the event any provision hereof should be held invalid or unenforceable in any respect, it shall not invalidate, render unenforceable or otherwise affect any other provision hereof. 
  
 11.7. No Recourse. Notwithstanding anything that may be expressed or
implied in this Agreement, each of the Company, Midco, Holdco and Merger Sub. and each Stockholder covenant, agree and acknowledge that no recourse under this Agreement shall be had against any current or future director, officer, employee, agent,
general or limited partner or member of the Company, Midco, Holdco, Merger Sub. or any Stockholder or of any Affiliate or assignee thereof, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any
statute, regulation or other applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any current or future director, officer, employee, agent,
partner or member of the Company, Midco, Holdco, Merger Sub. or any Stockholder or of any Affiliate or assignee thereof for any obligation to or of any Stockholder under this Agreement for any claim based on, in respect of or by reason of such
obligations or their creation; provided, however, that nothing in this Section 11.7 shall relieve any of the Company, Midco, Holdco, Merger Sub. or any Stockholder of its obligations hereunder. 
  
 11.8. Aggregation of Shares. All Shares held by a Stockholder and its
Affiliates and Affiliated Funds shall be aggregated together for purposes of determining the availability of any rights under Sections 3.3, 4 and 5. Within the group of a Stockholder and its Affiliates and Affiliated Funds, such Stockholders may
allocate the ability to exercise any rights under this Agreement in any manner that such group (by a Majority in Interest of the Shares held by such group) sees fit. 
  
 11.9. Obligations of Company, Midco, Holdco and Merger Sub. Each of the Company, Midco, Holdco and Merger Sub. shall
be jointly and severally liable for any payment obligation of any of the Company, Midco, Holdco and Merger Sub. pursuant to this Agreement. From and 

  

 -33- 

 
after the merger at the Closing, LifeCare shall be liable for all obligations of Merger Sub. pursuant to this Agreement. 
  
 12. GOVERNING LAW. 
  
 12.1. Governing Law. This Agreement and all claims arising out of or based upon this Agreement or relating to the
subject matter hereof shall be governed by and construed in accordance with the domestic substantive laws of the State of New York without giving effect to any choice or conflict of laws provision or rule that would cause the application of the
domestic substantive laws of any other jurisdiction. 
  
 12.2.
Consent to Jurisdiction. Each party to this Agreement, by its execution hereof, (a) hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the State of New York, County of New York for the
purpose of any action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation arising out of or based upon this Agreement or relating to the subject matter hereof, (b) hereby waives to the extent
not prohibited by applicable law, and agrees not to assert, and agrees not to allow any of its subsidiaries to assert, by way of motion, as a defense or otherwise, in any such action, any claim that it is not subject personally to the jurisdiction
of the above-named courts, that its property is exempt or immune from attachment or execution, that any such proceeding brought in one of the above-named courts is improper, or that this Agreement or the subject matter hereof or thereof may not be
enforced in or by such court and (c) hereby agrees not to commence or maintain any action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation arising out of or based upon this Agreement or
relating to the subject matter hereof or thereof other than before one of the above-named courts nor to make any motion or take any other action seeking or intending to cause the transfer or removal of any such action, claim, cause of action or suit
(in contract, tort or otherwise), inquiry, proceeding or investigation to any court other than one of the above-named courts whether on the grounds of inconvenient forum or otherwise. Notwithstanding the foregoing, to the extent that any party
hereto is or becomes a party in any litigation in connection with which it may assert indemnification rights set forth in this agreement, the court in which such litigation is being heard shall be deemed to be included in clause (a) above.
Notwithstanding the foregoing, any party to this Agreement may commence and maintain an action to enforce a judgment of any of the above-named courts in any court of competent jurisdiction. Each party hereto hereby consents to service of process in
any such proceeding in any manner permitted by New York law, and agrees that service of process by registered or certified mail, return receipt requested, at its address specified pursuant to Section 11.2 hereof is reasonably calculated to give
actual notice. 
  
 12.3. WAIVER OF JURY TRIAL. TO THE
EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH PARTY HERETO HEREBY WAIVES AND COVENANTS THAT IT WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE) ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE OR
ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR OTHERWISE), INQUIRY, PROCEEDING OR INVESTIGATION ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE
TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW 

  

 -34- 

 
EXISTING OR HEREAFTER ARISING. EACH PARTY HERETO ACKNOWLEDGES THAT IT HAS BEEN INFORMED BY THE OTHER PARTIES HERETO THAT THIS SECTION 12.3 CONSTITUTES A
MATERIAL INDUCEMENT UPON WHICH THEY ARE RELYING AND WILL RELY IN ENTERING INTO THIS AGREEMENT. ANY PARTY HERETO MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 12.3 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY TO
THE WAIVER OF ITS RIGHT TO TRIAL BY JURY. 
  
 12.4. Exercise of
Rights and Remedies. No delay of or omission in the exercise of any right, power or remedy accruing to any party as a result of any breach or default by any other party under this Agreement shall impair any such right, power or remedy, nor shall
it be construed as a waiver of or acquiescence in any such breach or default, or of any similar breach or default occurring later; nor shall any such delay, omission nor waiver of any single breach or default be deemed a waiver of any other breach
or default occurring before or after that waiver. 
  
 [Signature
pages follow] 
  

 -35- 

 IN WITNESS WHEREOF, each of the undersigned has duly executed this Agreement (or caused this Agreement to
be executed on its behalf by its officer or representative thereunto duly authorized) under seal as of the date first above written. 
  

									
	 LCI CORPORATIONS:
	 	 	 	 LCI HOLDING COMPANY, INC.
 LCI
INTERMEDIATE HOLDCO, INC.
 LCI HOLDCO, LLC
 RAINIER
ACQUISITION CORP.

					
	 	 	 	 	 	 	 By:
	 	/S/ W. EARL REED, III
	 	 	 	 	 	 	 	 	 Name: W. Earl Reed, III

	 	 	 	 	 	 	 	 	Title: Vice President

 The undersigned, as successor by merger to Rainier Acquisition Corp., hereby acknowledges and agrees that it is a party
to and bound by this Agreement as fully as if it had been the original signatory hereto in the place and stead of Rainier Acquisition Corp. 
  

									
	 THE COMPANY:
	 	 	 	LIFECARE HOLDINGS, INC.
					
	 	 	 	 	 	 	By:	 	/S/ W. EARL REED, III
	 	 	 	 	 	 	Name:	 	W. Earl Reed, III
	 	 	 	 	 	 	Title:	 	 President

									
	THE INVESTORS:	 	 	 	CARLYLE PARTNERS IV, L.P.
	 	 	 	 	By: TC Group IV, L.P., its general partner
	 	 	 	 	By: TC Group IV, L.L.C., its general partner
	 	 	 	 	By: TC Group, L.L.C., its sole member
	 	 	 	 	By: TCG Holdings, L.L.C. its managing member
				
	 	 	 	 	 	 	[Signature Appears Here]
	 	 	 	 	 	 	Name:	 	 
	 	 	 	 	 	 	Title:	 	 

  

									
	 	 	 	 	CP IV COINVESTMENT, L.P.
	 	 	 	 	By: TC Group IV, L.P., it general partner
	 	 	 	 	By: TC Group IV, L.L.C., its general partner
	 	 	 	 	By: TC Group, L.L.C., its sole member
	 	 	 	 	By: TCG Holdings, L.L.C. its managing member
				
	 	 	 	 	 	 	[Signature Appears Here]
	 	 	 	 	 	 	Name:	 	 
	 	 	 	 	 	 	Title:	 	 

 THE MANAGERS: 
  

			
	
	/S/ W. EARL REED, III
	Name:	 	W. Earl Reed
	Address:	 	 1667 Spring Drive

	 	 	 Louisville, KY 40205-1322

	
	/S/ RYAN D. BURKLOW
	Name:	 	Bryan D. Burklow
	Address:	 	 392 Sunny Acres Drive

	 	 	 Cincinnati,OH 43255

	
	/S/ JILL L. FORCE
	Name:	 	Jill L. Force
	Address:	 	 1732 Spring Drive

	 	 	 Louisville, KY 40205-1325

	
	/S/ WAYNE T. SMITH
	Name:	 	Wayne T. Smith
	Address:	 	c/o W.T. Smith’s Office
	 	 	 4175 Westport Road – Suite 102

	 	 	 Louisville, KY 40207

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}]]